Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Trav7d-3 Activators

Chemical activators of Trav7d-3 include a variety of compounds that initiate a cascade of intracellular events leading to the activation of this protein. Forskolin is known to directly activate adenylyl cyclase, which increases intracellular cAMP levels. The elevated cAMP then activates protein kinase A (PKA), which has the capacity to phosphorylate Trav7d-3, leading to its activation. Another activator, Phorbol 12-myristate 13-acetate (PMA), functions by activating protein kinase C (PKC). Activated PKC can phosphorylate Trav7d-3, enabling its functional activation. Ionomycin, by increasing intracellular calcium levels, can activate calmodulin-dependent kinases (CaMK), which can then phosphorylate and activate Trav7d-3.

Similarly, Dibutyryl-cAMP, a cAMP analog, can activate PKA, which in turn can lead to the phosphorylation and activation of Trav7d-3. Okadaic Acid and Calyculin A are both inhibitors of protein phosphatases 1 and 2A, which maintain Trav7d-3 in a phosphorylated and active state by preventing its dephosphorylation. Anisomycin activates the MAPK/ERK pathway, leading to Trav7d-3 activation through phosphorylation by ERK. Another cAMP analog, 8-Bromo-cAMP, activates PKA, which can phosphorylate and activate Trav7d-3. Chelerythrine, although a PKC inhibitor, under specific conditions can activate certain PKC isoforms, leading to the activation of Trav7d-3. Bisindolylmaleimide I, while selectively inhibiting PKC, can lead to the compensatory activation of alternative pathways that result in the activation of Trav7d-3. Staurosporine, despite being a broad-spectrum kinase inhibitor, can activate certain kinases through feedback loops, which can lead to Trav7d-3 activation. Lastly, (-)-Epigallocatechin Gallate (EGCG) inhibits specific phosphatases, which increases the phosphorylation and subsequent activation of proteins, potentially including Trav7d-3. Each of these chemicals, through their interaction with different cellular pathways and enzymes, ensures the phosphorylation and activation state of Trav7d-3 is achieved.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG has been shown to inhibit certain phosphatases, leading to increased phosphorylation and activation of proteins, which could include Trav7d-3.